 |
|
|
| |
Real-World Persistence to Long-Acting Cabotegravir Versus Oral PrEP for HIV
Prevention in Participants Using a Digital Health Companion Tool (AURORA Study)
|
| |
| |
IDWeek 2025 Oct 19-22 Atlanta
W. David Hardy, MD, AAHIVS1; Angela D. Settle, DNP, APRN, BC, FNP2; Kelly E. Pillinger, PharmD, BCIDP3; Leah Molloy, PharmD3; Laura Simone, PhD3;
Chris Napolitan3; Chelsie A. Chadha, PhD3; Melissa Rodriguez, MPH3; Jeff Carter, PhD3
(1) University of Southern California Keck School of Medicine, Los Angeles, CA; (2) West Virginia Health Right, Inc., Charleston, WV; (3) PRIME, New York, NY
|
| |
|
|
|
|
|
